葵花药业集团股份有限公司 关于复方聚乙二醇（3350）电解质口服溶液获得药品注册证书的公告

Group 1 - The company has received the drug registration certificate for Compound Polyethylene Glycol (3350) Electrolyte Oral Solution from the National Medical Products Administration [1][4] - The drug is approved for the treatment of chronic constipation and fecal impaction [3] - The product will enhance the company's "One Elderly" strategy, expanding its product matrix in the elderly care sector [4][2] Group 2 - The drug is classified as a Class 3 chemical drug and is a prescription medication [7] - The main components of the drug include Polyethylene Glycol 3350, Sodium Chloride, Potassium Chloride, and Sodium Bicarbonate [7] - The company plans to initiate mass production and market launch of the new product, leveraging its brand and marketing network [4][2]